Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...
The FDA has accepted the new drug application (NDA) for tirabrutinib (ONO-4059), a highly selective, irreversible, second-generation Bruton tyrosine kinase (BTK) inhibitor developed for the treatment ...
The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...
GLP-1 receptors are present throughout the brain and can contribute to a wide range of behaviors and conditions. (Drucker, Rinaman, Secher) Research is ongoing into which parts of the brain are ...
Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an ...
Sanofi has tapped Alloy Therapeutics to enable development of a central nervous system drug, agreeing to pay $27.5 million in upfront and near-term fees to access an antisense platform. Alloy is ...
Compared to Black and Asian people, white and Hispanic people with Alzheimer's disease and related dementias were most likely to be diagnosed with symptoms like depression and agitation, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results